(Q53521068)

English

Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10826401

Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10826401

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10826401

author name string

K Malmqvist

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10826401

M Dahl

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10826401

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10826401

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10826401

13

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10826401

5 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10826401

504-511

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10826401

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptom prevalence in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Subjective symptoms and well-being differ in women and men after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of antihypertensive medications on quality of life in elderly hypertensive women.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Perspectives on systolic hypertension. The Framingham study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of casual blood pressure variations

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen modulates AT1 receptor gene expression in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900264-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0895-7061(99)00264-2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10826401

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10826401

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53521068&oldid=2008835132"